Back to results
US 6,673,965 B1Granted
Hydroxamic acid derivative as inhibitor of the formation of soluble human CD23
AssigneeSmithKline Beecham Corporation
InventorsJohn Gerard Ward, Andrew Faller
Life of this patent
Estimating the term…
Abstract
A compound of formula (I) wherein: R isopropyl; n is 0; R1 is naphthylmethyl; R2 is t-butyl; and R3 is methyl; is useful in the treatment of disorders mediated by s-CD23.
Claims8
A compound of formula (I):
- wherein;
- R is isopropyl;
- n is 0;
- R1 is naphthylmethyl;
- R2 is t-butyl;
- and
- R3 methyl.
4 more elements
Dependencies are inferred from the claim text.